Literature DB >> 8827584

Multiple solutions, illegal parameter values, local minima of the sum of squares, and anomalous parameter estimates in least-squares fitting of the two-compartment pharmacokinetic model with absorption.

R D Purves1.   

Abstract

When the two-compartment model with absorption is fitted to data by nonlinear least squares, in general six different outcomes can be obtained, arising from permutation of the three exponential rate constants. The existence of multiple solutions in this sense is analogous to the flip-flop phenomenon in the one-compartment model. It is possible for parameter estimates to be inconsistent with the underlying physical model. Methods for recognizing such illegal estimates are described. Other common difficulties are that estimated values for two of the rate constants are almost identical with very large standard deviations, or that the parameter estimation algorithm converges poorly. Such unwanted outcomes usually signal a local (false) minimum of the sum of squares. They can be recognized from the ratio of largest to smallest singular value of the Jacobian matrix, and are, in principle, avoidable by starting the estimation algorithm with different initial values. There also exists a class of data sets for which all outcomes of fitting the usual equations are anomalous. A better fit to these data sets (smaller sum of squares) is obtained if two of the relevant rate constants are allowed to take complex conjugate values. Such data sets have usually been described as having "equal rate constants." A special form of the model equation is available for parameter estimation in this case. Precautions relating to its use are discussed.

Mesh:

Year:  1996        PMID: 8827584     DOI: 10.1007/bf02353511

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  15 in total

1.  Analytical study of open four compartment pharmacokinetic models: concentrations, area under curves, mean residence times.

Authors:  Y Plusquellec; G Houin
Journal:  J Biomed Eng       Date:  1990-07

2.  Unique pharmacokinetic characteristics of the one-compartment first-order absorption model with equal absorption and elimination rate constants.

Authors:  J G Zhi
Journal:  J Pharm Sci       Date:  1990-07       Impact factor: 3.534

3.  Analytical study of three-compartment pharmacokinetic models: concentration, area under curves, mean residence time.

Authors:  Y Plusquellec
Journal:  J Biomed Eng       Date:  1989-07

4.  Estimation problem due to multiple solutions in pharmacokinetic curve fitting to two-compartment model and its avoidance.

Authors:  K Murata; K Kohno
Journal:  Biopharm Drug Dispos       Date:  1989 Jan-Feb       Impact factor: 1.627

5.  Pharmacokinetic model equations for the one- and two-compartment models with first-order processes in which the absorption and exponential elimination or distribution rate constants are equal.

Authors:  H P Wijnand
Journal:  J Pharmacokinet Biopharm       Date:  1988-02

6.  Methods for estimating pharmacokinetic parameters should be thoroughly tested.

Authors:  R D Purves
Journal:  J Pharm Sci       Date:  1993-10       Impact factor: 3.534

7.  Numerical estimation of the noncompartmental pharmacokinetic parameters variance and coefficient of variation of residence times.

Authors:  R D Purves
Journal:  J Pharm Sci       Date:  1994-02       Impact factor: 3.534

8.  Anomalous parameter estimates in the one-compartment model with first-order absorption.

Authors:  R D Purves
Journal:  J Pharm Pharmacol       Date:  1993-10       Impact factor: 3.765

9.  A stable method for calculating oral drug absorption rate constants with two compartment disposition.

Authors:  L Saunders; T Natunen
Journal:  J Pharm Pharmacol       Date:  1973-12       Impact factor: 3.765

10.  A simple method for determining whether absorption and elimination rate constants are equal in the one-compartment open model with first-order processes.

Authors:  M Bialer
Journal:  J Pharmacokinet Biopharm       Date:  1980-02
View more
  7 in total

1.  Population pharmacokinetic analysis of mizolastine and validation from sparse data on patients using the nonparametric maximum likelihood method.

Authors:  F Mesnil; F Mentré; C Dubruc; J P Thénot; A Mallet
Journal:  J Pharmacokinet Biopharm       Date:  1998-04

2.  Pitfalls in pharmacokinetic multicompartment analysis.

Authors:  E Liang; H Derendorf
Journal:  J Pharmacokinet Biopharm       Date:  1998-04

3.  Bootstrapping for pharmacokinetic models: visualization of predictive and parameter uncertainty.

Authors:  C A Hunt; G H Givens; S Guzy
Journal:  Pharm Res       Date:  1998-05       Impact factor: 4.200

4.  Validation of a decision support system for use in drug development: pharmacokinetic data.

Authors:  S Guzy; C A Hunt
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

5.  Coupled solutions of one- and two-compartment pharmacokinetic models with first-order absorption.

Authors:  N Asmanova; G Koloskov; A I Ilin
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-04-10       Impact factor: 2.745

6.  A pharmacokinetic-pharmacodynamic study of a single dose of febuxostat in healthy subjects.

Authors:  Bishoy Kamel; Garry G Graham; Sophie L Stocker; Zhixin Liu; Kenneth M Williams; Jane E Carland; Kevin D Pile; Richard O Day
Journal:  Br J Clin Pharmacol       Date:  2020-06-18       Impact factor: 4.335

Review 7.  Clinical Pharmacokinetics and Pharmacodynamics of Febuxostat.

Authors:  Bishoy Kamel; Garry G Graham; Kenneth M Williams; Kevin D Pile; Richard O Day
Journal:  Clin Pharmacokinet       Date:  2017-05       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.